I am heartened to connect with you after a gap of 3 months through this July-September 2022 edition of Oviya MedSafe‘s newsletter (the 118th in the series since April 2012). While I was not happy to withhold the monthly stream of our newsletters, I had to do so for this brief period in order to get ourselves ready for the future. I also believed it would make sense to keep a low profile until we were prepared to make the next big announcement. And, here it is:
Oviya MedSafe now has a revamped website which aims not only to provide a more attractive user interface to the visitors but also to propel our digital journey to the next level as we enter into our second decade of life, while assuring an informative and secure browsing experience throughout. Of the new features, I personally like the Video Library which has been linked to our YouTube channel as this gives quick access to our treasure trove of knowledge in Pharmacovigilance as captured in our videos. Of course, more videos will keep coming. The website content is ‘work in progress‘ and you can expect to see updates coming up very soon and quite often. I seek all of your good wishes on this occasion as we embark on the next flight from excellence to beyond.
Speaking of tomorrow, we have recently been introspecting on the innate strengths of Oviya MedSafe as an organization and have begun building on them to accelerate our growth. I was delighted to comprehend that given the diverse clientele and the wide variety of Pharmacovigilance activities we have performed for our clients in the past 10 years, we already have unparalleled potential that just needs to be uncovered for Oviya MedSafe to emerge as one of the most successful Pharmacovigilance service providers in the world. I am sure this is because we remained ever open to reinventing ourselves in such a way that our offerings in Pharmacovigilance matched the business requirements of the pharma/biotech industry and I resolve to ensure this will stay the same always.
As the tailpiece, I wanted to share with you my joy in participating in the 9th Annual Pharmacovigilance Symposium of the Indian Society for Clinical Research (ISCR) which was held face-to-face after 3 years, on 23rd Sep 2022 at Mumbai! I had the honour of lighting the lamp along with the other dignitaries and participating as an expert panelist in the unique session “Student’s Corner (Campus to Corporate)” in which I shared the dais not only with my colleagues of the same league but also with youngsters who aspire to take up Pharmacovigilance as their career, resulting in intense cross-learning.
Please click here for some pictures from the event. Thanks to a friend in the audience, here is a brief video of my answer to a question on when Pharmacovigilance starts in the life cycle of a medicinal product. I regret the poor audio volume which is as it is from the source. Kindly use earphones. I hope such insights would benefit the next generation of Pharmacovigilance professionals.
Wishing you & yours a very Happy & Prosperous Deepavali in advance,
Keen to meet you soon with our October 2022 newsletter,
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA, FPIPA (UK)
Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Phone: +91 422 2444442
Oviya MedSafe UK Ltd,
Phone: +44 20 3393 6037
Follow us on Facebook, LinkedIn, Twitter & YouTube